Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.

Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.

Item
http://www.wikidata.org/entity/Q50196157
New developments for protein quality control.The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.Targeting multiple nodes of MLL complexes to improve leukemia therapy.Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells.The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability.Targeting oncoproteins for degradation by small molecules in myeloid leukemia.Unravelling the biology of chromatin in health and cancer using proteomic approaches.UBE2O is a quality control factor for orphans of multiprotein complexes.UBE2O remodels the proteome during terminal erythroid differentiation.Suppressing oncogenic transcription with a little healthy competition.Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin.New Insights into the Role of E2s in the Pathogenesis of Diseases: Lessons Learned from UBE2O.The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy
P2860

Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.

Item
http://www.wikidata.org/entity/Q50196157
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
@en
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
@nl
type
label
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
@en
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
@nl
prefLabel
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
@en
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
@en
P2093
P2860
P304
P31
P356
10.1016/J.CELL.2016.12.011
P407
P433
P478
P50
P577
P698
P921
P932